Arch Intern Med. 2010;170(9):821-827.
Background Epidemiological studies have consistently associated nut consumption with reduced risk for coronary heart disease. Subsequently, many dietary intervention trials investigated the effects of nut consumption on blood lipid levels. The objectives of this study were to estimate the effects of nut consumption on blood lipid levels and to examine whether different factors modify the effects.
Methods We pooled individual primary data from 25 nut consumption trials conducted in 7 countries among 583 men andwomen with normolipidemia and hypercholesterolemia who were not taking lipid-lowering medications. In a pooled analysis,we used mixed linear models to assess the effects of nut consumption and the potential interactions.
Results With a mean daily consumption of 67 g of nuts, the following estimated mean reductions were achieved: totalcholesterol concentration (10.9 mg/dL [5.1% change]), low-density lipoprotein cholesterol concentration (LDL-C) (10.2 mg/dL [7.4% change]), ratio of LDL-C to high-density lipoprotein cholesterol concentration (HDL-C) (0.22 [8.3% change]), and ratio of total cholesterol concentration to HDL-C (0.24 [5.6% change]) (P < .001 for all) (to convert all cholesterol concentrations to millimoles per liter, multiply by 0.0259). Triglyceride levels were reduced by 20.6 mg/dL (10.2%) in subjects with blood triglyceride levels of at least 150 mg/dL (P < .05) but not in those with lower levels (to convert triglyceride level to millimoles per liter, multiply by 0.0113). The effects of nut consumption were dose related, and different types of nuts had similar effects on blood lipid levels. The effects of nut consumption were significantly modified by LDL-C, body mass index, and diet type: the lipid-lowering effects of nut consumption were greatest among subjects with high baseline LDL-C and with low body mass index and among those consuming Western diets.
Conclusion Nut consumption improves blood lipid levels in a dose-related manner, particularly among subjects with higherLDL-C or with lower BMI.
Author Affiliations: Departments of Nutrition (Dr Sabaté) and Epidemiology and Biostatistics (Dr Sabaté and Mr Oda), Loma Linda University, Loma Linda, California; and Unitat de Lípids, Servei d’Endocrinologia i Nutrició, Institut d’Investigacions Biomèdiques August Pi Sunyer, Hospital Clínic de Barcelona, and Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Barcelona, Spain (Dr Ros).
No comments:
Post a Comment